Timothy S. Thorpe

Array ( [id] => 3650199 [patent_doc_number] => 05684134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Antibody specific for .beta.1.fwdarw.6 N-acetylglucosamininyltransferase' [patent_app_type] => 1 [patent_app_number] => 8/487069 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 10187 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684134.pdf [firstpage_image] =>[orig_patent_app_number] => 487069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041616 [patent_doc_number] => 05869055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Anti-inflammatory CD14 polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/484397 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12399 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869055.pdf [firstpage_image] =>[orig_patent_app_number] => 484397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905559 [patent_doc_number] => 06001360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Method and compositions for early detection and treatment of insulin dependent diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 8/474598 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14820 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001360.pdf [firstpage_image] =>[orig_patent_app_number] => 474598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804557 [patent_doc_number] => 05853999 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Methods of screening for agents that inhibit interaction between MHC class I antigens and a cell surface receptor' [patent_app_type] => 1 [patent_app_number] => 8/473656 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 24544 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 545 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853999.pdf [firstpage_image] =>[orig_patent_app_number] => 473656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768152 [patent_doc_number] => 05849575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Cloning and expression of host-protective immunogens of IBDV' [patent_app_type] => 1 [patent_app_number] => 8/481140 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 12721 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849575.pdf [firstpage_image] =>[orig_patent_app_number] => 481140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937680 [patent_doc_number] => 05976551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Altered major histocompatibility complex (MHC) determinant and method of using the determinant' [patent_app_type] => 1 [patent_app_number] => 8/484905 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 41068 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976551.pdf [firstpage_image] =>[orig_patent_app_number] => 484905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209735 [patent_doc_number] => 06028171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Class I MHC modulation of surface receptor activity' [patent_app_type] => 1 [patent_app_number] => 8/483931 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24961 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028171.pdf [firstpage_image] =>[orig_patent_app_number] => 483931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4247962 [patent_doc_number] => 06207389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Methods of controlling T lymphocyte mediated immune responses' [patent_app_type] => 1 [patent_app_number] => 8/477928 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 53 [patent_no_of_words] => 13939 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207389.pdf [firstpage_image] =>[orig_patent_app_number] => 477928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4225443 [patent_doc_number] => 06011146 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Altered major histocompatibility complex (MHC) determinant and methods of using the determinant' [patent_app_type] => 1 [patent_app_number] => 8/481985 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 40728 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011146.pdf [firstpage_image] =>[orig_patent_app_number] => 481985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827277 [patent_doc_number] => 05731420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltransferase' [patent_app_type] => 1 [patent_app_number] => 8/486196 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 11279 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731420.pdf [firstpage_image] =>[orig_patent_app_number] => 486196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232686 [patent_doc_number] => 06090387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Vaccination and methods against diseases resulting from pathogenic responses' [patent_app_type] => 1 [patent_app_number] => 8/472040 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 21371 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090387.pdf [firstpage_image] =>[orig_patent_app_number] => 472040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991081 [patent_doc_number] => 05985552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations' [patent_app_type] => 1 [patent_app_number] => 8/466860 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 21498 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985552.pdf [firstpage_image] =>[orig_patent_app_number] => 466860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685802 [patent_doc_number] => 05643741 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Identification and isolation of human hematopoietic stem cells' [patent_app_type] => 1 [patent_app_number] => 8/466659 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8983 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643741.pdf [firstpage_image] =>[orig_patent_app_number] => 466659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177837 [patent_doc_number] => 06159470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations' [patent_app_type] => 1 [patent_app_number] => 8/464506 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10135 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159470.pdf [firstpage_image] =>[orig_patent_app_number] => 464506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4148461 [patent_doc_number] => 06106840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'MHC conjugates useful in ameliorating autoimmunity' [patent_app_type] => 1 [patent_app_number] => 8/462351 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 23517 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/106/06106840.pdf [firstpage_image] =>[orig_patent_app_number] => 462351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795233 [patent_doc_number] => 05780597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Monoclonal antibodies to cytotoxic lymphocyte maturation factor' [patent_app_type] => 1 [patent_app_number] => 8/460061 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 41 [patent_no_of_words] => 26598 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780597.pdf [firstpage_image] =>[orig_patent_app_number] => 460061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3813389 [patent_doc_number] => 05710126 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'T cell epitopes of ryegrass pollen allergen' [patent_app_type] => 1 [patent_app_number] => 8/440861 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19344 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710126.pdf [firstpage_image] =>[orig_patent_app_number] => 440861 [rel_patent_id] =>[rel_patent_doc_number] =>)